Production (Stage)
Sanara MedTech Inc.
SMTI
$29.00
-$0.31-1.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -99.93% | -548.65% | -169.50% | -91.72% | -49.78% |
| Total Depreciation and Amortization | 1.72% | 0.62% | 10.64% | 37.55% | 41.92% |
| Total Amortization of Deferred Charges | 1,812.90% | 1,812.90% | 2,247.62% | -- | -- |
| Total Other Non-Cash Items | 166.24% | 193.20% | 244.47% | 126.06% | 310.27% |
| Change in Net Operating Assets | -21.23% | 150.92% | 223.27% | 29.57% | -23.22% |
| Cash from Operations | -25.37% | 209.84% | 92.70% | 17.90% | 8.44% |
| Capital Expenditure | -2,517.93% | -32.97% | 94.66% | -355.81% | -137.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -7,772.19% | -139.41% | 37.14% | -355.81% | -142.80% |
| Total Debt Issued | -- | -- | 57.16% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 88.16% | -1,791.18% | -71.04% | 91.50% | -0.44% |
| Cash from Financing | 1,919.72% | -545.99% | 56.47% | 846.07% | -787.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 307.40% | 63.36% | 5,663.69% | 370.93% | -38.65% |